シクロアストラゲノールの世界市場レポート2024-2030
英文タイトル: Global Cycloastragenol Market Insights, Forecast to 2030
販売価格(消費税別)
個人版
マルチユーザー版
企業版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=156.70円。
※米ドル表示価格+10%消費税。
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=156.70円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書は、シクロアストラゲノールの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にシクロアストラゲノール市場を分類しています。本レポートでは世界のシクロアストラゲノール市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は:NandR Bio Industries、Bio-norm、Xi'an Huisun Bio-Tech、Shaanxi Pioneer Biotech、Simagchem、Xi'an Lyphar Biotech、Xi'an SR Bio-Engineering、Changsha Comext Biotech
レポートはシクロアストラゲノールの主要生産者を調査し、主要地域や国の消費状況も提供します。シクロアストラゲノールの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。
2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。タイプ別市場セグメント:
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別(地域レベル、国レベル)のシクロアストラゲノール生産量、成長率、市場シェアを調査している。
Powder
Capsule
Others
用途別の市場セグメント:
Pharma and Healthcare
Food Additives
Cosmetic and Skin Care
Others
本レポートの詳細内容
本レポートは、世界のシクロアストラゲノール市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてシクロアストラゲノール市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
二. 消費面では、シクロアストラゲノールの売上高を地域別(地域レベル・国レベル)、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。
三.主要メーカーのシクロアストラゲノール売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のシクロアストラゲノール市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。
四.本シクロアストラゲノールのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。
章の概要第1章:シクロアストラゲノールのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー(タイプ別およびアプリケーション別など)を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。(2019~2030)
第2章: シクロアストラゲノールの世界と主要生産者(地域/国)の生産/アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。(2019~2030)
第3章:世界、地域、国レベルにおけるシクロアストラゲノールの売上(消費)、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。(2019~2030)
第4章シクロアストラゲノールメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。(2019~2024)
第5章:シクロアストラゲノールの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第6章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第7章:北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。(2019~2030)
第8章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高と収益。(2019~2030)
第9章:中国:タイプ別、アプリケーション別、セグメント別の売上高、収益。(2019~2030)
第10章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。(2019~2030)
第11章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。(2019~2030)
第12章:シクロアストラゲノールの主要メーカーの概要を提供し、製品の説明と仕様、シクロアストラゲノールの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。(2019~2024)
第13章:産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章:シクロアストラゲノールの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章:レポートの要点と結論。
概要
Cycloastragenol extract from astragalus Root. The global Cycloastragenol market is projected to grow from US$ 92 million in 2024 to US$ 111.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.3% during the forecast period. Plant extracts are substances or active substances with desired properties extracted from plant tissue and processed for a specific purpose. It is used in various fields, such as health foods, therapeutic drugs, cosmetics, processing aids, additives chemical substitutes. The market’s growth is driven by lifestyle changes, consumer awareness, increasing use of products based on natural ingredients, and biotechnology breakthroughs. Additionally, macroeconomic variables such as rising consumer disposable income, research and development, imports and exports, growth in the agriculture industry, population aging, and population growth have positively impacted the demand for plant extracts in recent years. It is also becoming increasingly popular in cosmetics, perfumes, pharmaceuticals, and dietary supplements. The plant extracts market was valued at USD 31.84 billion in 2022 and is expected to grow at a CAGR of 11.3% during the forecast period. In terms of production side, this report researches the Cycloastragenol production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030. In terms of consumption side, this report focuses on the sales of Cycloastragenol by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030. Report Covers: This report presents an overview of global market for Cycloastragenol, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of Cycloastragenol, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Cycloastragenol, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the Cycloastragenol sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Cycloastragenol market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Cycloastragenol sales, projected growth trends, production technology, application and end-user industry. Market Segmentation By Company NandR Bio Industries Bio-norm Xi'an Huisun Bio-Tech Shaanxi Pioneer Biotech Simagchem Xi'an Lyphar Biotech Xi'an SR Bio-Engineering Changsha Comext Biotech Segment by Type Powder Capsule Others Segment by Application Pharma and Healthcare Food Additives Cosmetic and Skin Care Others Production by Region North America Europe China Japan Sales by Region US & Canada U.S. Canada China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Europe Germany France U.K. Italy Russia Latin America, Middle East & Africa Brazil Mexico Turkey Israel GCC Countries Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Cycloastragenol production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years. Chapter 3: Sales (consumption), revenue of Cycloastragenol in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 4: Detailed analysis of Cycloastragenol manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment. Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment. Chapter 9: China by Type, and by Application, sales, and revenue for each segment. Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment. Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment. Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cycloastragenol sales, revenue, price, gross margin, and recent development, etc. Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers. Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 15: The main points and conclusions of the report.
総目録
1 Study Coverage
1.1 Cycloastragenol Product Introduction
1.2 Market by Type
1.2.1 Global Cycloastragenol Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Powder
1.2.3 Capsule
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cycloastragenol Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Pharma and Healthcare
1.3.3 Food Additives
1.3.4 Cosmetic and Skin Care
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Cycloastragenol Production
2.1 Global Cycloastragenol Production Capacity (2019-2030)
2.2 Global Cycloastragenol Production by Region: 2019 VS 2023 VS 2030
2.3 Global Cycloastragenol Production by Region
2.3.1 Global Cycloastragenol Historic Production by Region (2019-2024)
2.3.2 Global Cycloastragenol Forecasted Production by Region (2025-2030)
2.3.3 Global Cycloastragenol Production Market Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Cycloastragenol Revenue Estimates and Forecasts 2019-2030
3.2 Global Cycloastragenol Revenue by Region
3.2.1 Global Cycloastragenol Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Cycloastragenol Revenue by Region (2019-2024)
3.2.3 Global Cycloastragenol Revenue by Region (2025-2030)
3.2.4 Global Cycloastragenol Revenue Market Share by Region (2019-2030)
3.3 Global Cycloastragenol Sales Estimates and Forecasts 2019-2030
3.4 Global Cycloastragenol Sales by Region
3.4.1 Global Cycloastragenol Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Cycloastragenol Sales by Region (2019-2024)
3.4.3 Global Cycloastragenol Sales by Region (2025-2030)
3.4.4 Global Cycloastragenol Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Cycloastragenol Sales by Manufacturers
4.1.1 Global Cycloastragenol Sales by Manufacturers (2019-2024)
4.1.2 Global Cycloastragenol Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cycloastragenol in 2023
4.2 Global Cycloastragenol Revenue by Manufacturers
4.2.1 Global Cycloastragenol Revenue by Manufacturers (2019-2024)
4.2.2 Global Cycloastragenol Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Cycloastragenol Revenue in 2023
4.3 Global Cycloastragenol Sales Price by Manufacturers
4.4 Global Key Players of Cycloastragenol, Industry Ranking, 2022 VS 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Cycloastragenol Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Cycloastragenol, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Cycloastragenol, Product Offered and Application
4.8 Global Key Manufacturers of Cycloastragenol, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Cycloastragenol Sales by Type
5.1.1 Global Cycloastragenol Historical Sales by Type (2019-2024)
5.1.2 Global Cycloastragenol Forecasted Sales by Type (2025-2030)
5.1.3 Global Cycloastragenol Sales Market Share by Type (2019-2030)
5.2 Global Cycloastragenol Revenue by Type
5.2.1 Global Cycloastragenol Historical Revenue by Type (2019-2024)
5.2.2 Global Cycloastragenol Forecasted Revenue by Type (2025-2030)
5.2.3 Global Cycloastragenol Revenue Market Share by Type (2019-2030)
5.3 Global Cycloastragenol Price by Type
5.3.1 Global Cycloastragenol Price by Type (2019-2024)
5.3.2 Global Cycloastragenol Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Cycloastragenol Sales by Application
6.1.1 Global Cycloastragenol Historical Sales by Application (2019-2024)
6.1.2 Global Cycloastragenol Forecasted Sales by Application (2025-2030)
6.1.3 Global Cycloastragenol Sales Market Share by Application (2019-2030)
6.2 Global Cycloastragenol Revenue by Application
6.2.1 Global Cycloastragenol Historical Revenue by Application (2019-2024)
6.2.2 Global Cycloastragenol Forecasted Revenue by Application (2025-2030)
6.2.3 Global Cycloastragenol Revenue Market Share by Application (2019-2030)
6.3 Global Cycloastragenol Price by Application
6.3.1 Global Cycloastragenol Price by Application (2019-2024)
6.3.2 Global Cycloastragenol Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Cycloastragenol Market Size by Type
7.1.1 US & Canada Cycloastragenol Sales by Type (2019-2030)
7.1.2 US & Canada Cycloastragenol Revenue by Type (2019-2030)
7.2 US & Canada Cycloastragenol Market Size by Application
7.2.1 US & Canada Cycloastragenol Sales by Application (2019-2030)
7.2.2 US & Canada Cycloastragenol Revenue by Application (2019-2030)
7.3 US & Canada Cycloastragenol Sales by Country
7.3.1 US & Canada Cycloastragenol Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Cycloastragenol Sales by Country (2019-2030)
7.3.3 US & Canada Cycloastragenol Revenue by Country (2019-2030)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Cycloastragenol Market Size by Type
8.1.1 Europe Cycloastragenol Sales by Type (2019-2030)
8.1.2 Europe Cycloastragenol Revenue by Type (2019-2030)
8.2 Europe Cycloastragenol Market Size by Application
8.2.1 Europe Cycloastragenol Sales by Application (2019-2030)
8.2.2 Europe Cycloastragenol Revenue by Application (2019-2030)
8.3 Europe Cycloastragenol Sales by Country
8.3.1 Europe Cycloastragenol Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Cycloastragenol Sales by Country (2019-2030)
8.3.3 Europe Cycloastragenol Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Cycloastragenol Market Size by Type
9.1.1 China Cycloastragenol Sales by Type (2019-2030)
9.1.2 China Cycloastragenol Revenue by Type (2019-2030)
9.2 China Cycloastragenol Market Size by Application
9.2.1 China Cycloastragenol Sales by Application (2019-2030)
9.2.2 China Cycloastragenol Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Cycloastragenol Market Size by Type
10.1.1 Asia Cycloastragenol Sales by Type (2019-2030)
10.1.2 Asia Cycloastragenol Revenue by Type (2019-2030)
10.2 Asia Cycloastragenol Market Size by Application
10.2.1 Asia Cycloastragenol Sales by Application (2019-2030)
10.2.2 Asia Cycloastragenol Revenue by Application (2019-2030)
10.3 Asia Cycloastragenol Sales by Region
10.3.1 Asia Cycloastragenol Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Cycloastragenol Revenue by Region (2019-2030)
10.3.3 Asia Cycloastragenol Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Cycloastragenol Market Size by Type
11.1.1 Middle East, Africa and Latin America Cycloastragenol Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Cycloastragenol Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Cycloastragenol Market Size by Application
11.2.1 Middle East, Africa and Latin America Cycloastragenol Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Cycloastragenol Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Cycloastragenol Sales by Country
11.3.1 Middle East, Africa and Latin America Cycloastragenol Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Cycloastragenol Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Cycloastragenol Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 NandR Bio Industries
12.1.1 NandR Bio Industries Company Information
12.1.2 NandR Bio Industries Overview
12.1.3 NandR Bio Industries Cycloastragenol Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 NandR Bio Industries Cycloastragenol Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 NandR Bio Industries Recent Developments
12.2 Bio-norm
12.2.1 Bio-norm Company Information
12.2.2 Bio-norm Overview
12.2.3 Bio-norm Cycloastragenol Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 Bio-norm Cycloastragenol Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Bio-norm Recent Developments
12.3 Xi'an Huisun Bio-Tech
12.3.1 Xi'an Huisun Bio-Tech Company Information
12.3.2 Xi'an Huisun Bio-Tech Overview
12.3.3 Xi'an Huisun Bio-Tech Cycloastragenol Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 Xi'an Huisun Bio-Tech Cycloastragenol Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Xi'an Huisun Bio-Tech Recent Developments
12.4 Shaanxi Pioneer Biotech
12.4.1 Shaanxi Pioneer Biotech Company Information
12.4.2 Shaanxi Pioneer Biotech Overview
12.4.3 Shaanxi Pioneer Biotech Cycloastragenol Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 Shaanxi Pioneer Biotech Cycloastragenol Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Shaanxi Pioneer Biotech Recent Developments
12.5 Simagchem
12.5.1 Simagchem Company Information
12.5.2 Simagchem Overview
12.5.3 Simagchem Cycloastragenol Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.5.4 Simagchem Cycloastragenol Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Simagchem Recent Developments
12.6 Xi'an Lyphar Biotech
12.6.1 Xi'an Lyphar Biotech Company Information
12.6.2 Xi'an Lyphar Biotech Overview
12.6.3 Xi'an Lyphar Biotech Cycloastragenol Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.6.4 Xi'an Lyphar Biotech Cycloastragenol Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Xi'an Lyphar Biotech Recent Developments
12.7 Xi'an SR Bio-Engineering
12.7.1 Xi'an SR Bio-Engineering Company Information
12.7.2 Xi'an SR Bio-Engineering Overview
12.7.3 Xi'an SR Bio-Engineering Cycloastragenol Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.7.4 Xi'an SR Bio-Engineering Cycloastragenol Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Xi'an SR Bio-Engineering Recent Developments
12.8 Changsha Comext Biotech
12.8.1 Changsha Comext Biotech Company Information
12.8.2 Changsha Comext Biotech Overview
12.8.3 Changsha Comext Biotech Cycloastragenol Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.8.4 Changsha Comext Biotech Cycloastragenol Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Changsha Comext Biotech Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Cycloastragenol Industry Chain Analysis
13.2 Cycloastragenol Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Cycloastragenol Production Mode & Process
13.4 Cycloastragenol Sales and Marketing
13.4.1 Cycloastragenol Sales Channels
13.4.2 Cycloastragenol Distributors
13.5 Cycloastragenol Customers
14 Cycloastragenol Market Dynamics
14.1 Cycloastragenol Industry Trends
14.2 Cycloastragenol Market Drivers
14.3 Cycloastragenol Market Challenges
14.4 Cycloastragenol Market Restraints
15 Key Finding in The Global Cycloastragenol Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
表と図のリスト
List of Tables Table 1. Global Cycloastragenol Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Table 2. Major Manufacturers of Powder Table 3. Major Manufacturers of Capsule Table 4. Major Manufacturers of Others Table 5. Global Cycloastragenol Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Table 6. Global Cycloastragenol Production by Region: 2019 VS 2023 VS 2030 (MT) Table 7. Global Cycloastragenol Production by Region (2019-2024) & (MT) Table 8. Global Cycloastragenol Production by Region (2025-2030) & (MT) Table 9. Global Cycloastragenol Production Market Share by Region (2019-2024) Table 10. Global Cycloastragenol Production Market Share by Region (2025-2030) Table 11. Global Cycloastragenol Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 12. Global Cycloastragenol Revenue by Region (2019-2024) & (US$ Million) Table 13. Global Cycloastragenol Revenue by Region (2025-2030) & (US$ Million) Table 14. Global Cycloastragenol Revenue Market Share by Region (2019-2024) Table 15. Global Cycloastragenol Revenue Market Share by Region (2025-2030) Table 16. Global Cycloastragenol Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 17. Global Cycloastragenol Sales by Region (2019-2024) & (MT) Table 18. Global Cycloastragenol Sales by Region (2025-2030) & (MT) Table 19. Global Cycloastragenol Sales Market Share by Region (2019-2024) Table 20. Global Cycloastragenol Sales Market Share by Region (2025-2030) Table 21. Global Cycloastragenol Sales by Manufacturers (2019-2024) & (MT) Table 22. Global Cycloastragenol Sales Share by Manufacturers (2019-2024) Table 23. Global Cycloastragenol Revenue by Manufacturers (2019-2024) & (US$ Million) Table 24. Global Cycloastragenol Revenue Share by Manufacturers (2019-2024) Table 25. Cycloastragenol Price by Manufacturers 2019-2024 (USD/Kg) Table 26. Global Key Players of Cycloastragenol, Industry Ranking, 2022 VS 2023 VS 2024 Table 27. Global Cycloastragenol Manufacturers Market Concentration Ratio (CR5 and HHI) Table 28. Global Cycloastragenol by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cycloastragenol as of 2023) Table 29. Global Key Manufacturers of Cycloastragenol, Manufacturing Base Distribution and Headquarters Table 30. Global Key Manufacturers of Cycloastragenol, Product Offered and Application Table 31. Global Key Manufacturers of Cycloastragenol, Date of Enter into This Industry Table 32. Mergers & Acquisitions, Expansion Plans Table 33. Global Cycloastragenol Sales by Type (2019-2024) & (MT) Table 34. Global Cycloastragenol Sales by Type (2025-2030) & (MT) Table 35. Global Cycloastragenol Sales Share by Type (2019-2024) Table 36. Global Cycloastragenol Sales Share by Type (2025-2030) Table 37. Global Cycloastragenol Revenue by Type (2019-2024) & (US$ Million) Table 38. Global Cycloastragenol Revenue by Type (2025-2030) & (US$ Million) Table 39. Global Cycloastragenol Revenue Share by Type (2019-2024) Table 40. Global Cycloastragenol Revenue Share by Type (2025-2030) Table 41. Cycloastragenol Price by Type (2019-2024) & (USD/Kg) Table 42. Global Cycloastragenol Price Forecast by Type (2025-2030) & (USD/Kg) Table 43. Global Cycloastragenol Sales by Application (2019-2024) & (MT) Table 44. Global Cycloastragenol Sales by Application (2025-2030) & (MT) Table 45. Global Cycloastragenol Sales Share by Application (2019-2024) Table 46. Global Cycloastragenol Sales Share by Application (2025-2030) Table 47. Global Cycloastragenol Revenue by Application (2019-2024) & (US$ Million) Table 48. Global Cycloastragenol Revenue by Application (2025-2030) & (US$ Million) Table 49. Global Cycloastragenol Revenue Share by Application (2019-2024) Table 50. Global Cycloastragenol Revenue Share by Application (2025-2030) Table 51. Cycloastragenol Price by Application (2019-2024) & (USD/Kg) Table 52. Global Cycloastragenol Price Forecast by Application (2025-2030) & (USD/Kg) Table 53. US & Canada Cycloastragenol Sales by Type (2019-2024) & (MT) Table 54. US & Canada Cycloastragenol Sales by Type (2025-2030) & (MT) Table 55. US & Canada Cycloastragenol Revenue by Type (2019-2024) & (US$ Million) Table 56. US & Canada Cycloastragenol Revenue by Type (2025-2030) & (US$ Million) Table 57. US & Canada Cycloastragenol Sales by Application (2019-2024) & (MT) Table 58. US & Canada Cycloastragenol Sales by Application (2025-2030) & (MT) Table 59. US & Canada Cycloastragenol Revenue by Application (2019-2024) & (US$ Million) Table 60. US & Canada Cycloastragenol Revenue by Application (2025-2030) & (US$ Million) Table 61. US & Canada Cycloastragenol Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 62. US & Canada Cycloastragenol Revenue by Country (2019-2024) & (US$ Million) Table 63. US & Canada Cycloastragenol Revenue by Country (2025-2030) & (US$ Million) Table 64. US & Canada Cycloastragenol Sales by Country (2019-2024) & (MT) Table 65. US & Canada Cycloastragenol Sales by Country (2025-2030) & (MT) Table 66. Europe Cycloastragenol Sales by Type (2019-2024) & (MT) Table 67. Europe Cycloastragenol Sales by Type (2025-2030) & (MT) Table 68. Europe Cycloastragenol Revenue by Type (2019-2024) & (US$ Million) Table 69. Europe Cycloastragenol Revenue by Type (2025-2030) & (US$ Million) Table 70. Europe Cycloastragenol Sales by Application (2019-2024) & (MT) Table 71. Europe Cycloastragenol Sales by Application (2025-2030) & (MT) Table 72. Europe Cycloastragenol Revenue by Application (2019-2024) & (US$ Million) Table 73. Europe Cycloastragenol Revenue by Application (2025-2030) & (US$ Million) Table 74. Europe Cycloastragenol Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 75. Europe Cycloastragenol Revenue by Country (2019-2024) & (US$ Million) Table 76. Europe Cycloastragenol Revenue by Country (2025-2030) & (US$ Million) Table 77. Europe Cycloastragenol Sales by Country (2019-2024) & (MT) Table 78. Europe Cycloastragenol Sales by Country (2025-2030) & (MT) Table 79. China Cycloastragenol Sales by Type (2019-2024) & (MT) Table 80. China Cycloastragenol Sales by Type (2025-2030) & (MT) Table 81. China Cycloastragenol Revenue by Type (2019-2024) & (US$ Million) Table 82. China Cycloastragenol Revenue by Type (2025-2030) & (US$ Million) Table 83. China Cycloastragenol Sales by Application (2019-2024) & (MT) Table 84. China Cycloastragenol Sales by Application (2025-2030) & (MT) Table 85. China Cycloastragenol Revenue by Application (2019-2024) & (US$ Million) Table 86. China Cycloastragenol Revenue by Application (2025-2030) & (US$ Million) Table 87. Asia Cycloastragenol Sales by Type (2019-2024) & (MT) Table 88. Asia Cycloastragenol Sales by Type (2025-2030) & (MT) Table 89. Asia Cycloastragenol Revenue by Type (2019-2024) & (US$ Million) Table 90. Asia Cycloastragenol Revenue by Type (2025-2030) & (US$ Million) Table 91. Asia Cycloastragenol Sales by Application (2019-2024) & (MT) Table 92. Asia Cycloastragenol Sales by Application (2025-2030) & (MT) Table 93. Asia Cycloastragenol Revenue by Application (2019-2024) & (US$ Million) Table 94. Asia Cycloastragenol Revenue by Application (2025-2030) & (US$ Million) Table 95. Asia Cycloastragenol Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 96. Asia Cycloastragenol Revenue by Region (2019-2024) & (US$ Million) Table 97. Asia Cycloastragenol Revenue by Region (2025-2030) & (US$ Million) Table 98. Asia Cycloastragenol Sales by Region (2019-2024) & (MT) Table 99. Asia Cycloastragenol Sales by Region (2025-2030) & (MT) Table 100. Middle East, Africa and Latin America Cycloastragenol Sales by Type (2019-2024) & (MT) Table 101. Middle East, Africa and Latin America Cycloastragenol Sales by Type (2025-2030) & (MT) Table 102. Middle East, Africa and Latin America Cycloastragenol Revenue by Type (2019-2024) & (US$ Million) Table 103. Middle East, Africa and Latin America Cycloastragenol Revenue by Type (2025-2030) & (US$ Million) Table 104. Middle East, Africa and Latin America Cycloastragenol Sales by Application (2019-2024) & (MT) Table 105. Middle East, Africa and Latin America Cycloastragenol Sales by Application (2025-2030) & (MT) Table 106. Middle East, Africa and Latin America Cycloastragenol Revenue by Application (2019-2024) & (US$ Million) Table 107. Middle East, Africa and Latin America Cycloastragenol Revenue by Application (2025-2030) & (US$ Million) Table 108. Middle East, Africa and Latin America Cycloastragenol Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 109. Middle East, Africa and Latin America Cycloastragenol Revenue by Country (2019-2024) & (US$ Million) Table 110. Middle East, Africa and Latin America Cycloastragenol Revenue by Country (2025-2030) & (US$ Million) Table 111. Middle East, Africa and Latin America Cycloastragenol Sales by Country (2019-2024) & (MT) Table 112. Middle East, Africa and Latin America Cycloastragenol Sales by Country (2025-2030) & (MT) Table 113. NandR Bio Industries Company Information Table 114. NandR Bio Industries Description and Major Businesses Table 115. NandR Bio Industries Cycloastragenol Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024) Table 116. NandR Bio Industries Cycloastragenol Product Model Numbers, Pictures, Descriptions and Specifications Table 117. NandR Bio Industries Recent Development Table 118. Bio-norm Company Information Table 119. Bio-norm Description and Major Businesses Table 120. Bio-norm Cycloastragenol Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024) Table 121. Bio-norm Cycloastragenol Product Model Numbers, Pictures, Descriptions and Specifications Table 122. Bio-norm Recent Development Table 123. Xi'an Huisun Bio-Tech Company Information Table 124. Xi'an Huisun Bio-Tech Description and Major Businesses Table 125. Xi'an Huisun Bio-Tech Cycloastragenol Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024) Table 126. Xi'an Huisun Bio-Tech Cycloastragenol Product Model Numbers, Pictures, Descriptions and Specifications Table 127. Xi'an Huisun Bio-Tech Recent Development Table 128. Shaanxi Pioneer Biotech Company Information Table 129. Shaanxi Pioneer Biotech Description and Major Businesses Table 130. Shaanxi Pioneer Biotech Cycloastragenol Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024) Table 131. Shaanxi Pioneer Biotech Cycloastragenol Product Model Numbers, Pictures, Descriptions and Specifications Table 132. Shaanxi Pioneer Biotech Recent Development Table 133. Simagchem Company Information Table 134. Simagchem Description and Major Businesses Table 135. Simagchem Cycloastragenol Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024) Table 136. Simagchem Cycloastragenol Product Model Numbers, Pictures, Descriptions and Specifications Table 137. Simagchem Recent Development Table 138. Xi'an Lyphar Biotech Company Information Table 139. Xi'an Lyphar Biotech Description and Major Businesses Table 140. Xi'an Lyphar Biotech Cycloastragenol Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024) Table 141. Xi'an Lyphar Biotech Cycloastragenol Product Model Numbers, Pictures, Descriptions and Specifications Table 142. Xi'an Lyphar Biotech Recent Development Table 143. Xi'an SR Bio-Engineering Company Information Table 144. Xi'an SR Bio-Engineering Description and Major Businesses Table 145. Xi'an SR Bio-Engineering Cycloastragenol Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024) Table 146. Xi'an SR Bio-Engineering Cycloastragenol Product Model Numbers, Pictures, Descriptions and Specifications Table 147. Xi'an SR Bio-Engineering Recent Development Table 148. Changsha Comext Biotech Company Information Table 149. Changsha Comext Biotech Description and Major Businesses Table 150. Changsha Comext Biotech Cycloastragenol Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024) Table 151. Changsha Comext Biotech Cycloastragenol Product Model Numbers, Pictures, Descriptions and Specifications Table 152. Changsha Comext Biotech Recent Development Table 153. Key Raw Materials Lists Table 154. Raw Materials Key Suppliers Lists Table 155. Cycloastragenol Distributors List Table 156. Cycloastragenol Customers List Table 157. Cycloastragenol Market Trends Table 158. Cycloastragenol Market Drivers Table 159. Cycloastragenol Market Challenges Table 160. Cycloastragenol Market Restraints Table 161. Research Programs/Design for This Report Table 162. Key Data Information from Secondary Sources Table 163. Key Data Information from Primary Sources List of Figures Figure 1. Cycloastragenol Product Picture Figure 2. Global Cycloastragenol Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 3. Global Cycloastragenol Market Share by Type in 2023 & 2030 Figure 4. Powder Product Picture Figure 5. Capsule Product Picture Figure 6. Others Product Picture Figure 7. Global Cycloastragenol Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Figure 8. Global Cycloastragenol Market Share by Application in 2023 & 2030 Figure 9. Pharma and Healthcare Figure 10. Food Additives Figure 11. Cosmetic and Skin Care Figure 12. Others Figure 13. Cycloastragenol Report Years Considered Figure 14. Global Cycloastragenol Capacity, Production and Utilization (2019-2030) & (MT) Figure 15. Global Cycloastragenol Production Market Share by Region in Percentage: 2023 Versus 2030 Figure 16. Global Cycloastragenol Production Market Share by Region (2019-2030) Figure 17. Cycloastragenol Production Growth Rate in North America (2019-2030) & (MT) Figure 18. Cycloastragenol Production Growth Rate in Europe (2019-2030) & (MT) Figure 19. Cycloastragenol Production Growth Rate in China (2019-2030) & (MT) Figure 20. Cycloastragenol Production Growth Rate in Japan (2019-2030) & (MT) Figure 21. Global Cycloastragenol Revenue, (US$ Million), 2019 VS 2023 VS 2030 Figure 22. Global Cycloastragenol Revenue 2019-2030 (US$ Million) Figure 23. Global Cycloastragenol Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million) Figure 24. Global Cycloastragenol Revenue Market Share by Region in Percentage: 2023 Versus 2030 Figure 25. Global Cycloastragenol Revenue Market Share by Region (2019-2030) Figure 26. Global Cycloastragenol Sales 2019-2030 ((MT) Figure 27. Global Cycloastragenol Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (MT) Figure 28. Global Cycloastragenol Sales Market Share by Region (2019-2030) Figure 29. US & Canada Cycloastragenol Sales YoY (2019-2030) & (MT) Figure 30. US & Canada Cycloastragenol Revenue YoY (2019-2030) & (US$ Million) Figure 31. Europe Cycloastragenol Sales YoY (2019-2030) & (MT) Figure 32. Europe Cycloastragenol Revenue YoY (2019-2030) & (US$ Million) Figure 33. China Cycloastragenol Sales YoY (2019-2030) & (MT) Figure 34. China Cycloastragenol Revenue YoY (2019-2030) & (US$ Million) Figure 35. Asia (excluding China) Cycloastragenol Sales YoY (2019-2030) & (MT) Figure 36. Asia (excluding China) Cycloastragenol Revenue YoY (2019-2030) & (US$ Million) Figure 37. Middle East, Africa and Latin America Cycloastragenol Sales YoY (2019-2030) & (MT) Figure 38. Middle East, Africa and Latin America Cycloastragenol Revenue YoY (2019-2030) & (US$ Million) Figure 39. The Cycloastragenol Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023 Figure 40. The Top 5 and 10 Largest Manufacturers of Cycloastragenol in the World: Market Share by Cycloastragenol Revenue in 2023 Figure 41. Global Cycloastragenol Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023 Figure 42. Global Cycloastragenol Sales Market Share by Type (2019-2030) Figure 43. Global Cycloastragenol Revenue Market Share by Type (2019-2030) Figure 44. Global Cycloastragenol Sales Market Share by Application (2019-2030) Figure 45. Global Cycloastragenol Revenue Market Share by Application (2019-2030) Figure 46. US & Canada Cycloastragenol Sales Market Share by Type (2019-2030) Figure 47. US & Canada Cycloastragenol Revenue Market Share by Type (2019-2030) Figure 48. US & Canada Cycloastragenol Sales Market Share by Application (2019-2030) Figure 49. US & Canada Cycloastragenol Revenue Market Share by Application (2019-2030) Figure 50. US & Canada Cycloastragenol Revenue Share by Country (2019-2030) Figure 51. US & Canada Cycloastragenol Sales Share by Country (2019-2030) Figure 52. U.S. Cycloastragenol Revenue (2019-2030) & (US$ Million) Figure 53. Canada Cycloastragenol Revenue (2019-2030) & (US$ Million) Figure 54. Europe Cycloastragenol Sales Market Share by Type (2019-2030) Figure 55. Europe Cycloastragenol Revenue Market Share by Type (2019-2030) Figure 56. Europe Cycloastragenol Sales Market Share by Application (2019-2030) Figure 57. Europe Cycloastragenol Revenue Market Share by Application (2019-2030) Figure 58. Europe Cycloastragenol Revenue Share by Country (2019-2030) Figure 59. Europe Cycloastragenol Sales Share by Country (2019-2030) Figure 60. Germany Cycloastragenol Revenue (2019-2030) & (US$ Million) Figure 61. France Cycloastragenol Revenue (2019-2030) & (US$ Million) Figure 62. U.K. Cycloastragenol Revenue (2019-2030) & (US$ Million) Figure 63. Italy Cycloastragenol Revenue (2019-2030) & (US$ Million) Figure 64. Russia Cycloastragenol Revenue (2019-2030) & (US$ Million) Figure 65. China Cycloastragenol Sales Market Share by Type (2019-2030) Figure 66. China Cycloastragenol Revenue Market Share by Type (2019-2030) Figure 67. China Cycloastragenol Sales Market Share by Application (2019-2030) Figure 68. China Cycloastragenol Revenue Market Share by Application (2019-2030) Figure 69. Asia Cycloastragenol Sales Market Share by Type (2019-2030) Figure 70. Asia Cycloastragenol Revenue Market Share by Type (2019-2030) Figure 71. Asia Cycloastragenol Sales Market Share by Application (2019-2030) Figure 72. Asia Cycloastragenol Revenue Market Share by Application (2019-2030) Figure 73. Asia Cycloastragenol Revenue Share by Region (2019-2030) Figure 74. Asia Cycloastragenol Sales Share by Region (2019-2030) Figure 75. Japan Cycloastragenol Revenue (2019-2030) & (US$ Million) Figure 76. South Korea Cycloastragenol Revenue (2019-2030) & (US$ Million) Figure 77. China Taiwan Cycloastragenol Revenue (2019-2030) & (US$ Million) Figure 78. Southeast Asia Cycloastragenol Revenue (2019-2030) & (US$ Million) Figure 79. India Cycloastragenol Revenue (2019-2030) & (US$ Million) Figure 80. Middle East, Africa and Latin America Cycloastragenol Sales Market Share by Type (2019-2030) Figure 81. Middle East, Africa and Latin America Cycloastragenol Revenue Market Share by Type (2019-2030) Figure 82. Middle East, Africa and Latin America Cycloastragenol Sales Market Share by Application (2019-2030) Figure 83. Middle East, Africa and Latin America Cycloastragenol Revenue Market Share by Application (2019-2030) Figure 84. Middle East, Africa and Latin America Cycloastragenol Revenue Share by Country (2019-2030) Figure 85. Middle East, Africa and Latin America Cycloastragenol Sales Share by Country (2019-2030) Figure 86. Brazil Cycloastragenol Revenue (2019-2030) & (US$ Million) Figure 87. Mexico Cycloastragenol Revenue (2019-2030) & (US$ Million) Figure 88. Turkey Cycloastragenol Revenue (2019-2030) & (US$ Million) Figure 89. Israel Cycloastragenol Revenue (2019-2030) & (US$ Million) Figure 90. GCC Countries Cycloastragenol Revenue (2019-2030) & (US$ Million) Figure 91. Cycloastragenol Value Chain Figure 92. Cycloastragenol Production Process Figure 93. Channels of Distribution Figure 94. Distributors Profiles Figure 95. Bottom-up and Top-down Approaches for This Report Figure 96. Data Triangulation Figure 97. Key Executives Interviewed
01. サンプル提供
ご購入前にサンプル(英語、日本語)が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込(納品後、ご請求書送付)。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合:
レポート選択
見積もり依頼
メールでのご注文
入手(英語版は2〜4営業日、日本語版は8〜10営業日)
決済(後払い)
クレジットカード決済の場合:
レポート選択
ウェブサイトでのご注文
決済
入手(英語版は2〜4営業日、日本語版は8〜10営業日)